BACKGROUND: Breast density and body mass index (BMI) are used for breast cancer risk stratification. We evaluate whether the positive association between volumetric breast density and breast cancer risk is strengthened with increasing BMI. METHODS: The San Francisco Mammography Registry and Mayo Clinic Rochester identified 781 premenopausal and 1850 postmenopausal women with breast cancer diagnosed between 2007 and 2015 that had a screening digital mammogram at least 6 months prior to diagnosis. Up to three controls (N = 3535) were matched per case on age, race, date, mammography machine, and state. Volumetric percent density (VPD) and dense volume (DV) were measured with Volpara™. Breast cancer risk was assessed with logistic regression stratified by menopause status. Multiplicative interaction tests assessed whether the association of density measures was differential by BMI categories. RESULTS: The increased risk of breast cancer associated with VPD was strengthened with higher BMI for both premenopausal (pinteraction = 0.01) and postmenopausal (pinteraction = 0.0003) women. For BMI < 25, 25-30, and ≥ 30 kg/m2, ORs for breast cancer for a 1 SD increase in VPD were 1.24, 1.65, and 1.97 for premenopausal, and 1.20, 1.55, and 2.25 for postmenopausal women, respectively. ORs for breast cancer for a 1 SD increase in DV were 1.39, 1.33, and 1.51 for premenopausal (pinteraction = 0.58), and 1.31, 1.34, and 1.65 (pinteraction = 0.03) for postmenopausal women for BMI < 25, 25-30 and ≥ 30 kg/m2, respectively. CONCLUSIONS: The effect of volumetric percent density on breast cancer risk is strongest in overweight and obese women. These associations have clinical relevance for informing prevention strategies.
BACKGROUND: Breast density and body mass index (BMI) are used for breast cancer risk stratification. We evaluate whether the positive association between volumetric breast density and breast cancer risk is strengthened with increasing BMI. METHODS: The San Francisco Mammography Registry and Mayo Clinic Rochester identified 781 premenopausal and 1850 postmenopausal women with breast cancer diagnosed between 2007 and 2015 that had a screening digital mammogram at least 6 months prior to diagnosis. Up to three controls (N = 3535) were matched per case on age, race, date, mammography machine, and state. Volumetric percent density (VPD) and dense volume (DV) were measured with Volpara™. Breast cancer risk was assessed with logistic regression stratified by menopause status. Multiplicative interaction tests assessed whether the association of density measures was differential by BMI categories. RESULTS: The increased risk of breast cancer associated with VPD was strengthened with higher BMI for both premenopausal (pinteraction = 0.01) and postmenopausal (pinteraction = 0.0003) women. For BMI < 25, 25-30, and ≥ 30 kg/m2, ORs for breast cancer for a 1 SD increase in VPD were 1.24, 1.65, and 1.97 for premenopausal, and 1.20, 1.55, and 2.25 for postmenopausal women, respectively. ORs for breast cancer for a 1 SD increase in DV were 1.39, 1.33, and 1.51 for premenopausal (pinteraction = 0.58), and 1.31, 1.34, and 1.65 (pinteraction = 0.03) for postmenopausal women for BMI < 25, 25-30 and ≥ 30 kg/m2, respectively. CONCLUSIONS: The effect of volumetric percent density on breast cancer risk is strongest in overweight and obesewomen. These associations have clinical relevance for informing prevention strategies.
Entities:
Keywords:
Body mass index; Breast cancer; Breast density; Mammographic density
Authors: Karla Kerlikowske; Shuai Chen; Marzieh K Golmakani; Brian L Sprague; Jeffrey A Tice; Anna N A Tosteson; Garth H Rauscher; Louise M Henderson; Diana S M Buist; Janie M Lee; Charlotte C Gard; Diana L Miglioretti Journal: J Natl Cancer Inst Date: 2022-05-09 Impact factor: 11.816
Authors: Nickolas Dreher; Madeline Matthys; Edward Hadeler; Yiwey Shieh; Irene Acerbi; Fiona M McAuley; Michelle Melisko; Martin Eklund; Jeffrey A Tice; Laura J Esserman; Laura J Van't Veer Journal: Breast Cancer Res Treat Date: 2021-11-29 Impact factor: 4.624
Authors: Michael C S Bissell; Karla Kerlikowske; Brian L Sprague; Jeffery A Tice; Charlotte C Gard; Katherine Y Tossas; Garth H Rauscher; Amy Trentham-Dietz; Louise M Henderson; Tracy Onega; Theresa H M Keegan; Diana L Miglioretti Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-07-29 Impact factor: 4.254
Authors: Erin J Aiello Bowles; Suzanne C O'Neill; Tengfei Li; Sarah Knerr; Jeanne S Mandelblatt; Marc D Schwartz; Jinani Jayasekera; Kathleen Leppig; Kelly Ehrlich; David Farrell; Hongyuan Gao; Amanda L Graham; George Luta; Karen J Wernli Journal: J Womens Health (Larchmt) Date: 2021-09-28 Impact factor: 2.681
Authors: Ida Skarping; Daniel Förnvik; Uffe Heide-Jørgensen; Hanna Sartor; Per Hall; Sophia Zackrisson; Signe Borgquist Journal: Breast Date: 2020-06-04 Impact factor: 4.380
Authors: Anne Marie McCarthy; Yi Liu; Sarah Ehsan; Zoe Guan; Jane Liang; Theodore Huang; Kevin Hughes; Alan Semine; Despina Kontos; Emily Conant; Constance Lehman; Katrina Armstrong; Danielle Braun; Giovanni Parmigiani; Jinbo Chen Journal: Cancers (Basel) Date: 2021-12-23 Impact factor: 6.575